Trials / Completed
CompletedNCT04255992
Short Term Cardiovascular Effects and Oxidative Status of Calcium and Vitamin D Supplementation of Postmenopausal Hypertensive Blacks Women
Short Term Cardiovascular Effects and Oxidative Status of Calcium and Vitamin D Supplementation of Postmenopausal Hypertensive Blacks Women in Sub Saharan Africa
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- Yaounde Central Hospital · Other Government
- Sex
- Female
- Age
- 30 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to determine the effect of calcium and vitamin D supplementation on oxidative status and blood pressure profile of postmenopausal patients with high blood pressure in Yaoundé, Cameroon. This study is a double-arm, double-blind, randomized and parallel clinical trial conducted at the Yaoundé Central Hospital
Detailed description
Aim: to determine and compare the short term effect of calcium and vitamin D supplementation on oxidative status and blood pressure profile of postmenopausal patients with high blood pressure in Yaoundé, Cameroon. Method: A double-arm, double-blind, randomized and parallel clinical trial conducted at the Yaoundé Central Hospital. Postmenopausal hypertensive blacks women who are taking taking antihypertensives drugs since 12 months,without diabetes mellitus or any inflammatory disease or hypercalcemia, are randomize into 2 groups. Depending on the group, the intervention consisted of the administration of Calcium 1000 mg daily or Vitamin D/Calcium 1000 mg/800 UI daily for 08 weeks. The endpoints were the nycthemeral blood pressure profile, pro oxidant marker (malondialdehyde) and anti-oxidant marker (Ferric reducing antioxidant). Progress: Recruitment for this study was completed in May 2019 with 22 patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Calcium Arm | 1000 mg Calcium tablet / day will be added to the usual treatment for each patient for a period of 8 weeks. |
| DIETARY_SUPPLEMENT | Vitamin D/Calcium | 1000 mg/800UI of the association Vitamin D/Calcium tablet / day will be added to the usual treatment for each patient for a period of 8 weeks. |
Timeline
- Start date
- 2018-11-01
- Primary completion
- 2019-05-15
- Completion
- 2019-05-15
- First posted
- 2020-02-05
- Last updated
- 2020-02-05
Locations
1 site across 1 country: Cameroon
Source: ClinicalTrials.gov record NCT04255992. Inclusion in this directory is not an endorsement.